CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $525,934 | -52.8% | 31,721 | -47.1% | 0.10% | -63.3% |
| Q4 2022 | $1,114,307 | +19.7% | 59,909 | -17.4% | 0.27% | +25.9% |
| Q3 2022 | $931,000 | -14.0% | 72,562 | -53.0% | 0.21% | -27.1% |
| Q2 2022 | $1,082,000 | -3.6% | 154,367 | +14.0% | 0.29% | -3.6% |
| Q1 2022 | $1,122,000 | +117.4% | 135,381 | +77.7% | 0.30% | +70.6% |
| Q4 2021 | $516,000 | +207.1% | 76,200 | +140.4% | 0.18% | +221.8% |
| Q3 2021 | $168,000 | -32.0% | 31,700 | -26.1% | 0.06% | -46.1% |
| Q2 2021 | $247,000 | – | 42,900 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |